Manual push technique, an alternative route of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyradiculoneuropathy: A proof-of-concept study

• Published in: Clinical neurology and neurosurgery 2020-11, Vol.198, p.106240-106240, Article 106240
• Main Authors: Cocito, Dario, Peci, Erdita, Rigaldo, Simona, Canavese, Carlotta, Migliaretti, Giuseppe, Cossa, Federico M.
• Format: Article
• Language: English
• Subjects: Chronic inflammatory demyelinating polyradiculoneuropathy; Demyelinating diseases; Demyelination; Disability; Enrollments; Immunoglobulin G; Immunoglobulins; Inflammation; Infusion pumps; Medical records; Neurology; Neuropathology; Patients; Plasma; Polyneuropathy; Polyradiculitis; Quality of life; Randomized clinical trial
• ISSN: 0303-8467; 1872-6968
• DOI: 10.1016/j.clineuro.2020.106240

•Patients affected by CIDP were enrolled in this proof-of-concept study.•Manual push technique (MPT) is widely used to administer SCIg in PIDD patients.•Also in CIDP patients MPT proved clinically effective and improved QoL. Subcutaneous immunoglobulin (SCIg) administered through infusion pump has been reported as effective in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. In this study we evaluate an alternative technique of SCIg administration, based on the delivery of lower volumes administered daily using manual push technique (MPT) in 10 CIDP patients. In this randomized, controlled, two-arm, crossover clinical trial, CIDP patients were randomly assigned 1:1 to receive SCIg either by MPT or pumps for 4 consecutive months with crossover to the other. The primary objective was to assess whether MPT had the same effectiveness as pumps. The secondary objectives were to assess whether MPT resulted in greater plasma IgG levels and improved quality of life (QoL). Ten patients (mean age = 48.3) were enrolled. No significant changes were observed in the efficacy parameters (INCAT, MRC, R-ODS, and GS scales). A positive mean variation of 5.4 % in plasma IgG levels in the group treated with MPT was observed at the end of MPT periods. Treatment interference, which is one of the dimensions of the Life Quality Index, showed a significant improvement in the MPT periods. In CIDP patients, the MPT technique was as effective as pump infusion, allowed comparable, slightly increases plasma IgG levels, and also improved the QoL.